News Summary

• Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development.
• is a publicly traded (NASDAQ: INMB) late-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease.
• (Nasdaq: QUBT) is an integrated quantum photonics company developing technologies that use light to use complex information, capture hard-to-detect signals and communicate more securely.